ANA ISABEL
MUÑAGORRI SANTOS
Ikertzailea 2022-(e)ra arte
![Foto de ANA ISABEL](/img/nophoto.png)
![Foto de Hospital de Cruces](/img/noimage_org.png)
Hospital de Cruces
Barakaldo, EspañaHospital de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2018
-
Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors
Digestive and Liver Disease, Vol. 50, Núm. 8, pp. 812-819